Loading people...
Helen Routh is a Venture Partner at Nina Capital and an independent board director based in the Greater New York City Area. At Nina Capital, she helps manage over €100 million across three funds, investing in a portfolio of more than 50 early-stage health technology companies. She concurrently serves as a non-executive director for several medical technology firms, including Ultromics, Clarius Mobile Health, Quantivly, and Agfa. Prior to her venture capital and advisory work, Routh spent nearly two decades in senior leadership roles at Philips, where she served as Senior Vice President of Strategy and Innovation and General Manager of Philips Research North America. Holding a doctorate in medical ultrasound physics from Cardiff University, her current professional focus centers on guiding early-stage digital health ventures through the integration of artificial intelligence and advanced medical imaging.
Helen Routh is a distinguished Venture Partner at Nina Capital, a leading venture capital firm renowned for its strategic investments in the healthcare sector. In her pivotal role, Helen is instrumental in sourcing, evaluating, and supporting innovative early-stage companies that are poised to transform healthcare delivery and patient outcomes. Her work at Nina Capital involves a deep dive into emerging technologies and business models, ensuring that the firm backs ventures with significant potential for growth and impact.
Nina Capital's investment thesis centers on digital health, medical devices, diagnostics, and health IT, areas where Helen Routh brings considerable expertise. She is particularly focused on companies that leverage technology to address critical unmet needs in healthcare, improve efficiency, and enhance accessibility. This includes solutions in areas such as AI-driven diagnostics, telemedicine platforms, personalized medicine, remote patient monitoring, and data analytics for healthcare providers. Helen's keen eye for disruptive innovation helps Nina Capital identify the next generation of healthcare leaders.
Helen's career background is marked by a strong foundation in both the operational and strategic aspects of the healthcare industry. Prior to her role at Nina Capital, she held significant positions that provided her with a comprehensive understanding of healthcare ecosystems, from clinical operations to business development in health technology firms. This diverse experience equips her with a unique perspective, enabling her to not only assess the technological viability of a startup but also its market potential and operational scalability. Her ability to connect with founders and provide meaningful guidance is a testament to her hands-on approach and deep industry network.
At Nina Capital, Helen Routh is more than just an investor; she is a strategic partner to the portfolio companies. She actively engages with founders, offering mentorship, strategic advice, and connecting them with crucial resources to accelerate their growth. Her commitment extends beyond capital injection, focusing on building robust companies that can navigate the complex healthcare landscape and achieve sustainable success. While specific notable investments are not publicly detailed, her influence is evident in the strategic direction and growth trajectory of the innovative companies Nina Capital supports, solidifying her reputation as a key figure in healthcare venture capital.
Helen Routh is a Venture Partner at Nina Capital, a venture capital firm specializing in healthcare investments. She focuses on identifying and supporting early-stage companies in digital health and medical technology.
Helen Routh invests in early-stage healthcare technology companies, with a focus on digital health, medical devices, diagnostics, and health IT. Her interests include AI-driven solutions, telemedicine, personalized medicine, and remote patient monitoring.
Helen Routh works as a Venture Partner at Nina Capital, a leading venture capital firm dedicated to investing in and fostering innovation within the healthcare sector.
